WVE (Wave Life Sciences) Total Debt per Share: $0.23 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WVE Wave Life Sciences Inc WVE
58 GF Score
Price $5.42
GF Value $4.09
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Wave Life Sciences Total Debt per Share?

Wave Life Sciences WVE +4.24% 58 Total Debt per Share is $0.23 as of Jun. 2026. GuruFocus rates WVE with a GF Score™ of 58/100 and a GF Value™ of $4.09 (Significantly Overvalued). The stock has 4 warning signs investors should review.

$0.23 (As of Jun. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Wave Life Sciences's Total Debt Per Share for the quarter that ended in Jun. 2026 was $0.23.

Wave Life Sciences Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Wave Life Sciences's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wave Life Sciences Total Debt per Share Chart

Wave Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Debt per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.43 0.27 0.17 0.10

Wave Life Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Debt per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.14 0.12 0.10 0.08 0.23
WVE
58GF Score
Wave Life Sciences Inc WVE
Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Wave Life Sciences Total Debt per Share Calculation

Wave Life Sciences's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(9.41+8.36)/187.66
=0.09

Wave Life Sciences's Total Debt Per Share for the quarter that ended in Jun. 2026 is calculated as:

Total Debt Per Share=(Long-Term Debt & Capital Lease Obligation+Short-Term Debt & Capital Lease Obligation)/Shares Outstanding (EOP)
=(40.08+3.51)/193.28
=0.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Debt per Share →
What does a Total Debt per Share of $0.23 mean?
Wave Life Sciences (WVE) has a Total Debt per Share of $0.23 as of Jun. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Wave Life Sciences and its competitors.
Is Wave Life Sciences' Total Debt per Share too high?
Wave Life Sciences' current Total Debt per Share is $0.23. Overall, Wave Life Sciences has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Wave Life Sciences' Total Debt per Share compare to FBRX and SVRA?
Wave Life Sciences' Total Debt per Share of $0.23 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Debt per Share for a Biotechnology company?
A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Debt per Share mean?
A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Wave Life Sciences and its competitors. Wave Life Sciences's current Total Debt per Share is $0.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wave Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Wave Life Sciences (WVE) is currently considered Significantly Overvalued. The stock's GF Value™ is $4.09, compared to a current price of $5.42 — trading 32.4% above its estimated fair value. The current Total Debt per Share is $0.23. Wave Life Sciences' overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Debt per Share calculated?
Total Debt per Share is calculated from a company's financial statements. For Wave Life Sciences (WVE), the current Total Debt per Share is $0.23 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Wave Life Sciences (WVE) Overvalued in 2026?

Based on GuruFocus' analysis, Wave Life Sciences stock appears to be overvalued. The current stock price of $5.42 is trading 32.4% above its estimated GF Value™ of $4.09. GuruFocus considers Wave Life Sciences to be Significantly Overvalued.

Key valuation signals for WVE:

  • Total Debt per Share: $0.23
  • GF Value™: $4.09 vs. price of $5.42 (32.4% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the WVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Wave Life Sciences Business Description

Other Exchanges 1U5:Germany
Address 7 Straits View No. 12-00, Marina One East Tower, Singapore, SGP, 018936
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
58GF Score

Get the complete analysis for WVE

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.42
Price
$4.09
GF Value